224 related articles for article (PubMed ID: 33388858)
1. Curcuminoids supplementation ameliorates iron overload, oxidative stress, hypercoagulability, and inflammation in non-transfusion-dependent β-thalassemia/Hb E patients.
Hatairaktham S; Masaratana P; Hantaweepant C; Srisawat C; Sirivatanauksorn V; Siritanaratkul N; Panichkul N; Kalpravidh RW
Ann Hematol; 2021 Apr; 100(4):891-901. PubMed ID: 33388858
[TBL] [Abstract][Full Text] [Related]
2. Role of curcuminoids in ameliorating oxidative modification in β-thalassemia/Hb E plasma proteome.
Weeraphan C; Srisomsap C; Chokchaichamnankit D; Subhasitanont P; Hatairaktham S; Charoensakdi R; Panichkul N; Siritanaratkul N; Fucharoen S; Svasti J; Kalpravidh RW
J Nutr Biochem; 2013 Mar; 24(3):578-85. PubMed ID: 22818714
[TBL] [Abstract][Full Text] [Related]
3. Improvement in oxidative stress and antioxidant parameters in beta-thalassemia/Hb E patients treated with curcuminoids.
Kalpravidh RW; Siritanaratkul N; Insain P; Charoensakdi R; Panichkul N; Hatairaktham S; Srichairatanakool S; Phisalaphong C; Rachmilewitz E; Fucharoen S
Clin Biochem; 2010 Mar; 43(4-5):424-9. PubMed ID: 19900435
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of deferiprone in transfusion-independent beta-thalassemia/HbE patients.
Akrawinthawong K; Chaowalit N; Chatuparisuth T; Siritanaratkul N
Hematology; 2011 Mar; 16(2):113-22. PubMed ID: 21418744
[TBL] [Abstract][Full Text] [Related]
5. Grape seed extract in combination with deferasirox ameliorates iron overload, oxidative stress, inflammation, and liver dysfunction in beta thalassemia children.
Mottaghi S; Abbaszadeh H
Complement Ther Clin Pract; 2023 Nov; 53():101804. PubMed ID: 37832335
[TBL] [Abstract][Full Text] [Related]
6. Treatment of β-Thalassemia/Hemoglobin E with Antioxidant Cocktails Results in Decreased Oxidative Stress, Increased Hemoglobin Concentration, and Improvement of the Hypercoagulable State.
Yanpanitch OU; Hatairaktham S; Charoensakdi R; Panichkul N; Fucharoen S; Srichairatanakool S; Siritanaratkul N; Kalpravidh RW
Oxid Med Cell Longev; 2015; 2015():537954. PubMed ID: 26078808
[TBL] [Abstract][Full Text] [Related]
7. Intracellular iron overload leading to DNA damage of lymphocytes and immune dysfunction in thalassemia major patients.
Shaw J; Chakraborty A; Nag A; Chattopadyay A; Dasgupta AK; Bhattacharyya M
Eur J Haematol; 2017 Nov; 99(5):399-408. PubMed ID: 28815805
[TBL] [Abstract][Full Text] [Related]
8. Iron overload and iron-chelating therapy in hemoglobin E-beta thalassemia.
Olivieri NF; De Silva S; Premawardena A; Sharma S; Viens AM; Taylor CM; Brittenham GM; Weatherall DJ
J Pediatr Hematol Oncol; 2000; 22(6):593-7. PubMed ID: 11132236
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of advanced glycation end products positively correlate with iron overload and oxidative stress markers in patients with β-thalassemia major.
Mirlohi MS; Yaghooti H; Shirali S; Aminasnafi A; Olapour S
Ann Hematol; 2018 Apr; 97(4):679-684. PubMed ID: 29318368
[TBL] [Abstract][Full Text] [Related]
10. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
Daar S; Pathare AV
Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
[TBL] [Abstract][Full Text] [Related]
11. Serum Hepcidin as a Diagnostic Marker of Severe Iron Overload in Beta-thalassemia Major.
Kaddah AM; Abdel-Salam A; Farhan MS; Ragab R
Indian J Pediatr; 2017 Oct; 84(10):745-750. PubMed ID: 28600663
[TBL] [Abstract][Full Text] [Related]
12. Effects of curcuminoids on inflammatory and oxidative stress biomarkers and clinical outcomes in critically ill patients: A randomized double-blind placebo-controlled trial.
Zahedi H; Hosseinzadeh-Attar MJ; Shadnoush M; Sahebkar A; Barkhidarian B; Sadeghi O; Najafi A; Hosseini S; Qorbani M; Ahmadi A; Ardehali SH; Norouzy A
Phytother Res; 2021 Aug; 35(8):4605-4615. PubMed ID: 34080237
[TBL] [Abstract][Full Text] [Related]
13. Differentially expressed plasma proteins of β-thalassemia/hemoglobin E patients in response to curcuminoids/vitamin E antioxidant cocktails.
Panachan J; Chokchaichamnankit D; Weeraphan C; Srisomsap C; Masaratana P; Hatairaktham S; Panichkul N; Svasti J; Kalpravidh RW
Hematology; 2019 Dec; 24(1):300-307. PubMed ID: 30661467
[TBL] [Abstract][Full Text] [Related]
14. Iron status and oxidative stress in beta-thalassemia patients in Jakarta.
Laksmitawati DR; Handayani S; Udyaningsih-Freisleben SK; Kurniati V; Adhiyanto C; Hidayat J; Kusnandar S; Dillon HS; Munthe BG; Wirawan R; Soegianto RR; Ramelan W; Freisleben HJ
Biofactors; 2003; 19(1-2):53-62. PubMed ID: 14757977
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Deferasirox (Exjade®) in Modulation of Iron Overload in Patients with β-Thalassemia Intermedia.
Karimi M; Arandi N; Haghpanah S; Ansari S; Azarkeyvan A; Bordbar M; Safaei S
Hemoglobin; 2015; 39(5):327-9. PubMed ID: 26114738
[TBL] [Abstract][Full Text] [Related]
16. Serum ferritin is not a reliable predictor to determine iron overload in thalassemia major patients post-hematopoietic stem cell transplantation.
Jarisch A; Salzmann-Manrique E; Cario H; Grosse R; Soerensen J; Fischer R; Schulz A; Hammerstingl R; Wunderlich A; Bader P
Eur J Haematol; 2018 Dec; 101(6):791-797. PubMed ID: 30187571
[TBL] [Abstract][Full Text] [Related]
17. N-Acetylcysteine supplementation reduces oxidative stress and DNA damage in children with β-thalassemia.
Ozdemir ZC; Koc A; Aycicek A; Kocyigit A
Hemoglobin; 2014; 38(5):359-64. PubMed ID: 25222041
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of serum ferritin and iron burden by intake of antioxidants in beta thalassemia major.
Bhagat SS; Sarkar PD; Suryakar AN; Padalkar RK; Ghone RA; Patil SM; Hundekar PS
Indian J Physiol Pharmacol; 2013; 57(2):189-94. PubMed ID: 24617170
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of different iron chelators in Egyptian children with Beta Thalassemia with iron overload.
Hagag AA; Hamam MA; Taha OA; Hazaa SM
Infect Disord Drug Targets; 2015; 15(2):98-105. PubMed ID: 26205801
[TBL] [Abstract][Full Text] [Related]
20. Real-life experience with liver iron concentration R2 MRI measurement in patients with hemoglobinopathies: baseline data from LICNET.
Vitrano A; Calvaruso G; Tesé L; Gioia F; Cassarà F; Campisi S; Butera F; Commendatore V; Rizzo M; Santoro V; Cigna V; Quota A; Bagnato S; Argento C; Fidone C; Schembari D; Gerardi C; Barbiera F; Bellisssima G; Giugno G; Polizzi G; Rosso R; Abbate G; Caruso V; Chiodi E; Gamberini MR; Giorgi B; Putti MC; Filosa A; De Ritis MR; Oliva E; Arcadi N; Fustaneo M; Mistretta L; Di Maggio R; Sacco M; Veronica DS; Giangreco A; Maggio A
Eur J Haematol; 2016 Oct; 97(4):361-70. PubMed ID: 26818147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
